Skip to main content
. 2004 Mar 2;90(5):955–961. doi: 10.1038/sj.bjc.6601579

Table 2. Adverse events reported during CC-5013 treatment.

Patient Graded diagnosis NCI toxicity grade Causal relationship to REVIMID treatment
2 Nausea and Vomiting Grade 2 Remote
  Fatigue Grade 2 Possible
  Altered taste Grade 2 Possible
  Hot flushes Grade 1 Possible
  Occasional cramps Grade 1 Possible
4 Papular rash Grade 1 Possible
6 Papular rash Grade 2 Possible
8 Cramps Grade 1 Possible
  Fatigue Grade 2 Possible
13 Altered taste Grade 1 Possible – although there is a local lesion
16 Jaundice Grade 2 Remote
17 Numbness Grade 2 Possible
18 Fatigue Grade 2 Possible
20 Macular rash Grade 1 Probable